Cargando…

Chronic Active Hepatitis B with COVID-19 in Pregnancy: A Case Report

Currently, infection with coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), during pregnancy is a problem worthy of attention, especially in patients with underlying diseases. In this case report, we present a case of chronic active hepatiti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Qiu-Yu, An, Zhuo-Yu, Li, Chao, Zu, Ming, Chen, Lei, Zhang, Jia-Nan, Zhao, Yang-Yu, Shen, Ning, Ge, Qing-Gang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	XIA & HE Publishing Inc. 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868702/ https://www.ncbi.nlm.nih.gov/pubmed/33604264 http://dx.doi.org/10.14218/JCTH.2020.00085

Ejemplares similares

Safety of entecavir antiviral therapyduring an accidental pregnancy in patients with chronic hepatitis B
por: Cao, Lihua, et al.
Publicado: (2023)

Association of Cytokines with Alanine Aminotransferase, Hepatitis B Virus Surface Antigen and Hepatitis B Envelope Antigen Levels in Chronic Hepatitis B
por: Li, Ming-Hui, et al.
Publicado: (2018)

Negative Correlation of Serum Hepatitis B Surface Antigen and Hepatitis B e Antigen Levels with the Severity of Liver Inflammation in Treatment-naïve Patients with Chronic Hepatitis B Virus Infection
por: Zhang, Lu, et al.
Publicado: (2017)

Clinical features and outcome of acute hepatitis B in pregnancy
por: Han, Yong-Tao, et al.
Publicado: (2014)

Kinetics of Hepatitis B Surface Antigen Level in Chronic Hepatitis B Patients who Achieved Hepatitis B Surface Antigen Loss during Pegylated Interferon Alpha-2a Treatment
por: Li, Ming-Hui, et al.
Publicado: (2017)

On-treatment monitoring of liver fibrosis with serum hepatitis B core-related antigen in chronic hepatitis B
por: Chang, Xiu-Juan, et al.
Publicado: (2019)

On-treatment quantitative hepatitis B e antigen predicted response to nucleos(t)ide analogues in chronic hepatitis B
por: Gao, Yu-Hua, et al.
Publicado: (2016)

Management of chronic hepatitis B during pregnancy
por: Aslam, Aysha, et al.
Publicado: (2018)

Antibody to Hepatitis B Core Antigen Levels in the Natural History of Chronic Hepatitis B: A Prospective Observational Study
por: Jia, Wei, et al.
Publicado: (2014)

Tenofovir disoproxil fumarate in Chinese chronic hepatitis B patients: Results of a multicenter, double-blind, double-dummy, clinical trial at 96 weeks
por: Chen, Xiao-Fan, et al.
Publicado: (2021)

Factors associated with significant liver necroinflammation in chronic hepatitis B patients with cirrhosis
por: Chen, Sheng-Sen, et al.
Publicado: (2016)

Soluble programmed death-1 is predictive of hepatitis B surface antigen loss in chronic hepatitis B patients after antiviral treatment
por: Tan, Ning, et al.
Publicado: (2021)

Short-term Peginterferon-Induced High Functional Cure Rate in Inactive Chronic Hepatitis B Virus Carriers With Low Surface Antigen Levels
por: Zeng, Qing-Lei, et al.
Publicado: (2020)

Efficacy of a Chinese herbal formula on hepatitis B e antigen-positive chronic hepatitis B patients
por: Xing, Yu-Feng, et al.
Publicado: (2020)

Total cholesterol to high-density lipoprotein ratio and nonalcoholic fatty liver disease in a population with chronic hepatitis B
por: Zhou, Yu-Ge, et al.
Publicado: (2022)

Safety of hepatitis B virus core antibody-positive grafts in liver transplantation: A single-center experience in China
por: Lei, Ming, et al.
Publicado: (2018)

PNPLA3 rs1010023 Predisposes Chronic Hepatitis B to Hepatic Steatosis but Improves Insulin Resistance and Glucose Metabolism
por: Pan, Qin, et al.
Publicado: (2017)

Development and validation of a model for staging hepatic fibrosis for chronic hepatitis B patients with E antigen-positive
por: Wang, Hong, et al.
Publicado: (2017)

240‐week entecavir maleate treatment in Chinese chronic hepatitis B predominantly genotype B or C
por: Xu, Jing‐Hang, et al.
Publicado: (2022)

Maternal hepatitis B virus carrier status and pregnancy outcomes: a prospective cohort study
por: Cui, Ai-Ming, et al.
Publicado: (2016)

Gut microbiota alteration and modulation in hepatitis B virus-related fibrosis and complications: Molecular mechanisms and therapeutic inventions
por: Li, Yao-Guang, et al.
Publicado: (2022)

Chronic hepatitis B in pregnancy: unique challenges and opportunities
por: Yogeswaran, Kumaresan, et al.
Publicado: (2011)

Multifaceted Interaction Between Hepatitis B Virus Infection and Lipid Metabolism in Hepatocytes: A Potential Target of Antiviral Therapy for Chronic Hepatitis B
por: Zhang, Jiaxuan, et al.
Publicado: (2021)

Lowering the threshold of alanine aminotransferase for enhanced identification of significant hepatic injury in chronic hepatitis B patients
por: Yu, Hong-Sheng, et al.
Publicado: (2023)

Fatigue in chronic hepatitis B patients is significant and associates with autonomic dysfunction
por: Wang, Hong, et al.
Publicado: (2019)

Management of chronic myelogenous leukemia with COVID-19 and hepatitis B
por: Yu, Tian, et al.
Publicado: (2023)

Serum cytokine profiling analysis for zheng differentiation in chronic hepatitis B
por: Lu, Yi-Yu, et al.
Publicado: (2015)

Advances in new antivirals for chronic hepatitis B
por: Tang, Yanhua, et al.
Publicado: (2022)

Immunomodulatory Effects of Combination Therapy with Bushen Formula plus Entecavir for Chronic Hepatitis B Patients
por: Ji, Long-Shan, et al.
Publicado: (2019)

Advantages of a Novel Model for Predicting Hepatic Fibrosis in Chronic Hepatitis B Virus Carriers Compared with APRI and FIB-4 Scores
por: Kang, Na-Ling, et al.
Publicado: (2022)

Evaluation of elastography combined with serological indexes for hepatic fibrosis in patients with chronic hepatitis B
por: Xu, Bin, et al.
Publicado: (2018)

Pegylated-Interferon Alpha Therapy for Treatment-Experienced Chronic Hepatitis B Patients
por: Yeh, Ming-Lun, et al.
Publicado: (2015)

The effects of the insulin resistance index on the virologic response to entecavir in patients with HBeAg-positive chronic hepatitis B and nonalcoholic fatty liver disease
por: Zhu, Li-Yao, et al.
Publicado: (2016)

Serum IL-21 levels associated with chronic hepatitis B and hepatitis B-related liver failure
por: CHEN, HONG-MEI, et al.
Publicado: (2014)

Serum lipid alterations identified in chronic hepatitis B, hepatitis B virus-associated cirrhosis and carcinoma patients
por: Wu, Tao, et al.
Publicado: (2017)

Genotype Matters in Patients with Acute-on-chronic Liver Failure Due to Reactivation of Chronic Hepatitis B
por: Wan, Yue-Meng, et al.
Publicado: (2018)

Corrigendum to “Immunomodulatory Effects of Combination Therapy with Bushen Formula plus Entecavir for Chronic Hepatitis B Patients”
por: Ji, Long-Shan, et al.
Publicado: (2022)

Maternal Hepatitis B Virus Infection and Pregnancy Outcomes of Freeze-Thaw Embryo Transfer
por: Ruan, Ling-Ling, et al.
Publicado: (2023)

Hepatitis B in pregnancy
por: Dyson, Jessica Katharine, et al.
Publicado: (2014)

Long-Term Effect of Interferon Plus Ribavirin on Hepatitis B Surface Antigen Seroclearance in Patients Dually Infected with Hepatitis B and C Viruses
por: Yeh, Ming-Lun, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_d3le9of86ibuugqcakf7t5tlmv